Brief: LogicBio Therapeutics Announces Pre-Clinical Results For mLB-001 Published In Peer-Reviewed Journal PLOS ONE
21/09/2022 14:02
Sept 21 (Reuters) - LogicBio Therapeutics Inc LOGC.O :
* LOGICBIO® THERAPEUTICS ANNOUNCES PRE-CLINICAL RESULTS FOR
MLB-001 PUBLISHED IN PEER-REVIEWED JOURNAL PLOS ONE
Source text for Eikon: ID:nPn7tS7Dya
Further company coverage: LOGC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on ContextLogic Holdings
See all newsContextLogic Holdings Q2 revenue flat as higher prices offset lower volumes
Brief: ContextLogic Holdings Q2 Adjusted EBITDA USD 10.8 Million
ContextLogic Holdings Q1 net income jumps on tax benefit
Brief: ContextLogic Holdings Q1 Net Income USD 17 Million
Brief: Contextlogic To Acquire US Salt From Emerald Lake In $907.5 Million Transaction, Creating New Business Ownership Platform In Partnership With Abrams Capital And BC Partners Credit